TISBURY PHARMACEUTICALS
Tisbury Pharmaceuticals discovers, develops, and commercializes therapy to treat primary open angle glaucoma. The company's clinical candidate, R-801, accelerates flow via the trabecular meshwork via redox catalysis and K+-ATP (channel activation). The company was incorporated in 2017 and is based in Beverly, Massachusetts.
TISBURY PHARMACEUTICALS
Industry:
Clinical Trials Health Care Medical Pharmaceutical
Founded:
2017-01-01
Address:
Beverly, Massachusetts, United States
Country:
United States
Website Url:
http://www.tisburypharmaceuticals.com
Total Employee:
11+
Status:
Closed
Total Funding:
32 M USD
Technology used in webpage:
IPhone / Mobile Compatible Nginx OpenResty Google Adsense AdBlock Acceptable Ads Google Adsense For Domains LeaseWeb
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Founder
Investors List
OrbiMed
OrbiMed investment in Series A - Tisbury Pharmaceuticals
Clarus Healthcap
Clarus Healthcap investment in Series A - Tisbury Pharmaceuticals
Pontifax
Pontifax investment in Series A - Tisbury Pharmaceuticals
HealthCap
HealthCap investment in Series A - Tisbury Pharmaceuticals
Official Site Inspections
http://www.tisburypharmaceuticals.com
Unable to get host informations!!!
